• Cy5 TSA Fluorescence System Kit for Liver Imaging

  2026-09-20

  The Cy5 TSA Fluorescence System Kit converts localized HRP activity into a bright, covalently deposited far-red signal for challenging IHC, ICC, and FISH experiments. Its strongest use case is spatially resolved detection of scarce or developmentally restricted targets, such as immature hepatobiliary populations highlighted by recent Hippo pathway research.

• β-Elemene Inhibits Adipogenesis via AMPK

  2026-09-19

  The reference study identifies β-Elemene as an inhibitor of MDI-induced adipogenesis in 3T3-L1 adipocytes and connects this phenotype with recovery of AMPK-pathway activity. Its cell-based design also links reduced lipid accumulation with improved glucose handling in an insulin-resistance model, while leaving in vivo efficacy and direct target validation for future research.

• Vancomycin hydrochloride: Assay Workflows

  2026-09-18

  Build more reproducible Gram-positive susceptibility studies with Vancomycin hydrochloride as a mechanism-defined benchmark for cell-wall inhibition and resistance profiling. The workflow also shows how antibiofilm study design can add time-kill, adherence, and mature-biofilm endpoints without confusing peptide activity with vancomycin performance.

• Sulfo-Cy5 NHS Ester for Immune Imaging

  2026-09-18

  Sulfo-Cy5 NHS ester enables aqueous fluorescent labeling of immune biomolecules without organic co-solvents. This article explains how to use its far-red optical profile to design more discriminating uptake, receptor-localization, and nanostructure-immunology assays.

• AZD6482: Translational Precision Beyond PI3Kβ

  2026-09-17

  AZD6482 offers a highly selective route to interrogate PI3Kβ across platelet, metabolic, and signaling models. This thought-leadership guide connects its established pharmacology with disciplined exploratory study design in DM1 RNA-foci research while separating evidence from hypothesis.

• Partial BACE1 Inhibition and Synaptic Transmission

  2026-09-17

  Satir et al. show that partial β-secretase inhibition can reduce amyloid-β secretion without impairing synaptic transmission in cultured rat cortical neurons. The study identifies a functional exposure window in which amyloid-beta production inhibition remains compatible with neuronal signaling, while stronger inhibition produces synaptic effects.

• N6-Methyl-dATP in DNA Fidelity Workflows

  2026-09-16

  N6-Methyl-dATP enables controlled experiments on how an N6-methyl group changes DNA polymerase recognition, extension, and fidelity. This practical guide connects defined nucleotide-substitution assays with orthogonal AML research workflows, helping investigators distinguish biochemical effects from downstream genomic-stability phenotypes.

• Cy5 TSA Fluorescence System Kit for Cancer Imaging

  2026-09-16

  The Cy5 TSA Fluorescence System Kit converts modest HRP activity into a bright, localized far-red signal for challenging ICC, IHC, and FISH assays. Its value is especially clear when mapping low-abundance components of the p53-R280K/SREBP1/FASN axis while conserving scarce antibodies and preserving spatial context.

• Topotecan (SKF104864) Cancer Research Workflows

  2026-09-15

  Topotecan (SKF104864) converts a topoisomerase I mechanism into practical assays for viability, DNA damage, apoptosis, and cell-cycle response. This workflow-oriented guide covers glioma, pediatric tumor, combination, and translational experiments while addressing dosing, solubility, controls, and interpretation.

• Cy5 TSA Fluorescence System Kit Workflow

  2026-09-15

  Learn how to apply the Cy5 TSA Fluorescence System Kit to sensitive IHC, ICC, and FISH workflows, with practical conditions for HRP-mediated signal deposition. The guide connects spatial detection of lipid-metabolism markers with the miR-3180 hepatocellular carcinoma study and provides troubleshooting strategies for low signal, background, and imaging artifacts.

• AMG 9810: A Translational TRPV1 Research Framework

  2026-09-14

  AMG 9810 offers a mechanism-first way to interrogate TRPV1 signaling, linking stimulus-specific ion-channel activity with calcium influx, CGRP release, and sensory neuron phenotypes. This perspective outlines how to use the compound rigorously while interpreting emerging metabolic-stress biology without overstating cross-domain evidence.

• Praeruptorin A: Applied Research Workflows

  2026-09-14

  Praeruptorin A supports mechanism-led studies spanning ferroptosis, inflammation, intestinal barrier repair, cardiomyopathy research, and tumor-cell invasion. This workflow shows how to separate pathway modulation from nonspecific cytotoxicity while improving solubility control, orthogonal validation, and assay reproducibility.

• Vancomycin Hydrochloride in Translational Resistance Researc

  2026-09-13

  Vancomycin hydrochloride is more than a routine positive control: its defined D-alanyl-D-alanine binding mechanism can anchor bacterial susceptibility testing, dynamic resistance studies, and Clostridium difficile infection model design. This thought-leadership guide connects glycopeptide biology with semi-mechanistic PKPD principles from contemporary resistance research while clarifying where the evidence is established and where translational validation is still needed.

• Triiodothyronine T3 in Adipose Thermogenesis

  2026-09-12

  Triiodothyronine (T3) provides a reversible, receptor-proximal probe for separating thyroid hormone signaling from SETD7-dependent control of white adipose browning. This workflow combines T3 dose–time testing with thermogenic gene expression, mitochondrial phenotyping, and epistasis experiments to strengthen metabolic disorder research.

• DATCPT Nanocarriers for Orthotopic Pancreatic Cancer

  2026-09-12

  The ACS Nano study introduces DATCPT, a pH/reactive oxygen species-responsive nanocarrier that sequentially adapts its surface charge, remodels tumor stroma, and releases camptothecin in orthotopic pancreatic cancer. Its main contribution is a coordinated strategy for addressing circulation, extracellular matrix, tumor penetration, and metastatic barriers rather than treating each obstacle independently.

8508 records 1/568 page Next 12345 下5页 Last page